All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, San Diego Dr. Eric D. Adler MD Early Translational III Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease $1,701,575
University of California, Davis Walter Douglas Boyd Early Translational III Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair $4,631,754
Stanford University Dr. Bertha Chen Early Translational III Autologous iPSC Therapy for Urinary Incontinence $4,715,738
University of California, San Diego Mark H Tuszynski Early Translational III Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury $4,600,447
University of California, Davis Prof. Kyriacos A. Athanasiou Ph.D Early Translational III Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells $1,735,703
University of California, Irvine Craig M. Walsh Early Translational III Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells $4,535,005
Scripps Research Institute Peter G. Schultz Early Translational III Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis $2,559,333
University of California, San Francisco Dr. Arnold Kriegstein Early Translational III Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury $1,623,251
University of California, San Diego Gene Wei-Ming Yeo Early Translational III Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons $1,532,323
University of California, Santa Cruz Dr. David Haussler Training Grant I-3 Training Program in Systems Biology of Stem Cells $1,133,701
University of California, Santa Barbara Dr. Dennis O. Clegg Training Grant I-3 UCSB Stem Cell Biology Training Program $975,334
Salk Institute for Biological Studies Juan Carlos Izpisua Belmonte Training Grant I-3 Training in the Biology of Human Enbryonic Stem Cells and Emerging Technologies $1,261,333
California Institute of Technology Paul H. Patterson Training Grant I-2 Training in Stem Cell Biology at CIT $1,817,214
Children’s Hospital of Los Angeles Dr. Donald B. Kohn Training Grant I-2 Training Grant 1 $2,173,872
Sanford Burnham Prebys Medical Discovery Institute Dr. Mark Mercola Training Grant I-2 Burnham Institute CIRM Stem Cell Training Grant (Type II) $1,061,865
Gladstone Institutes, J. David Dr. Robert W Mahley Training Grant I-2 Gladstone CIRM Scholar Program $2,192,073
Scripps Research Institute Peter G. Schultz Training Grant I-2 Training Grant I $1,021,395
University of California, Davis Dr. Frederick J Meyers MD Training Grant I-1 Stem Cell Research Training Grant $1,780,859
University of California, San Francisco Dr. Susan J Fisher PhD Training Grant I-1 Training Grant I $2,868,145
University of California, Los Angeles Dr. Owen N Witte M.D. Training Grant I-1 CIRM Type I Comprehensive Training Program $3,660,398
University of Southern California Dr. Robert E Maxson Training Grant I-1 CIRM Stem Cell Biology Training Grant $2,332,431
University of California, Irvine Dr. Peter Bryant Training Grant I-1 Stem Cell Research Training Grant $1,935,487
University of California, Berkeley Randy W. Schekman Training Grant I-1 Human Stem Cell Training at UC Berkeley and Childrens Hospital of Oakland $2,360,457
University of California, San Diego Dr. Lawrence S. B. Goldstein Training Grant I-1 Interdisciplinary Stem Cell Training Program at UCSD $3,459,396
Stanford University Michael T. Longaker M.D. Training Grant I-1 Stanford CIRM Training Program $3,035,282
University of California, Davis Dr Mehrdad Abedi Disease Team Therapy Planning I Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients $66,880
University of California, Davis Dr. John Laird Disease Team Therapy Planning I Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia $76,066
University of California, Davis Dr. Vicki Wheelock Disease Team Therapy Planning I MSC engineered to produce BDNF for the treatment of Huntington’s disease $97,564
Cedars-Sinai Medical Center Professor Clive Niels Svendsen Disease Team Therapy Planning I Stem Cells Secreting GDNF for the Treatment of ALS $63,487
Stanford University Dr. Albert J Wong Disease Team Therapy Planning I Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma $109,750
Stanford University Dr. Judith A Shizuru Disease Team Therapy Planning I A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $90,147
OncoMed Pharmaceuticals, Inc. Timothy Hoey Disease Team Therapy Planning I Anti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency $65,120
Cedars-Sinai Medical Center Dr. Dan Gazit Disease Team Therapy Planning I Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures. $107,622
StemCells, Inc. Dr. Alexandra Capela Disease Team Therapy Planning I Neuroprotection to treat Alzheimer’s: a new paradigm using human central nervous system cells $90,101
University of California, Los Angeles Dr. Stanley Nelson Disease Team Therapy Planning I Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy $68,947
Geron Corporation Dr. Jane Stephanie Lebkowski Dr. Disease Team Therapy Planning I Preclinical Development and First-In-Human Testing of GRNCM1 in Advanced Heart Failure $0
Sanford Burnham Prebys Medical Discovery Institute Dr. Marcel Daadi Dr. Disease Team Therapy Planning I Neural Stem Cell-Based Therapy For Parkinson’s Disease $63,952
Sanford Burnham Prebys Medical Discovery Institute Dr. Stuart A Lipton Disease Team Therapy Planning I hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease $96,448
University of California, Davis Nancy E. Lane Disease Team Therapy Planning I Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis $107,750
University of Southern California Roberta Diaz Brinton Disease Team Therapy Planning I A CIRM Disease Team to Develop Allopregnanolone for Prevention and Treatment of Alzheimer’s Disease $107,961
Samumed, LLC John Hood Disease Team Therapy Planning I Clinical Development of an osteoinductive therapy to prevent osteoporosis-related fractures $99,110
Stanford University Dr. Robert Robbins Disease Team Therapy Planning I Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $73,030
University of California, Davis Dr. Martin Birchall Disease Team Therapy Planning I Airways for Children $19,800
University of California, Los Angeles Dr. Antoni Ribas MD/PhD Disease Team Therapy Planning I Genetic Re-programming of Stem Cells to Fight Cancer $97,785
California State University San Marcos Corporation Dr. Bianca Romina Mothé Bridges California State University-San Marcos CIRM Bridges to the Stem Cell Research Training Grant $4,114,712
Cal State Univ, Long Beach Dr. Lisa S Klig Bridges CIRM Stem Cell Research Biotechnology Training Program at CSULB $3,487,091
Cal Poly Pomona Foundation Dr. Jill Adler-Moore Bridges Cal Poly Pomona and Cal State LA Collaborative CIRM Bridges Program to Enhance Stem Cell Research Training and Education $3,056,191
San Francisco State University Dr. Carmen Domingo Bridges SFSU Bridges to Stem Cell Research $4,168,243
Humboldt State University Sponsored Programs Foundation Dr. Jacob Varkey Bridges The HSU CIRM Bridges to Stem Cell Research Certificate Program $3,195,858
San Diego State University Foundation Ralph Feuer Bridges SDSU/CIRM Stem Cell Internship Program $4,156,315
1 2 3 4 5 6 7 8 9 10 11 … 30